Clairo

Sr. Financial Analyst

United States

Clairo Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Financial Services, Corporate FinanceIndustries

Requirements

Candidates should possess a Bachelor’s degree in Accounting, Finance, or a related field, with an MBA or CPA being a plus. They require 3+ years of progressive experience in financial planning and analysis, along with advanced knowledge of Excel, Word, and PowerPoint. Previous experience with M&A transactions and foreign currency accounting is considered a beneficial asset.

Responsibilities

The Senior Financial Analyst will serve as a key financial partner for assigned business segments, preparing comprehensive forecasts, budgets, and trend analysis packages. They will monitor and analyze key performance indicators, providing insights to business leaders, investigating and explaining material variances, and building and maintaining cost models. This role involves producing timely financial reports, supporting corporate initiatives such as M&A and profit margin analysis, and collaborating with internal teams to resolve issues and identify process improvements, while also providing financial support to the CFO and senior leadership as needed.

Skills

Excel
Word
PowerPoint
Financial analysis
Forecasting
Budgeting
Variance analysis
Cost modeling
M&A
Process improvement

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

Key Metrics

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI